Karolinska Institutet: Prostatic Neoplasms trials
The registry lists 16 Prostatic Neoplasms studies with Karolinska Institutet as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 3 1No phase 15(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered ValidationNot yet recruitingNCT06573736
- To Live Better After Prostate Cancer Treatment:RecruitingNCT05100121Not applicable
- ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate CancerRecruitingNCT03903835Phase 3
- Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial EmulationCompletedNCT07206693
- Long-term Outcomes of Prostate Cancer ScreeningActive, not recruitingNCT07155759Not applicable
- Genetic Studies of Prostate Cancer Aggressiveness and PrognosisCompletedNCT06773858
- Prostate Cancer IRE Study (PRIS)Active, not recruitingNCT05513443Not applicable
- Exercise as Medicine for People With Cancer SwedenCompletedNCT05064670Not applicable
- US/MRI Fusion Local Anestesia TransPerineal Prostate Biopsies for Detection of Prostate CancerWithdrawnNCT04797078Not applicable
- STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate CancerCompletedNCT04627948
- Stockholm3 Validation Study in a Multi-Ethnic CohortCompletedNCT04583072
- Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active SurveillanceCompletedNCT03956108Not applicable
- STHLM3 - Prostate Cancer Diagnostic TrialCompletedNCT03639649Not applicable
- Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion BiopsiesActive, not recruitingNCT03377881Not applicable
- STHLM3-MR: Comparing Standard With Targeted Prostate BiopsiesCompletedNCT02788825Not applicable
- Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate CancerCompletedNCT02477137Not applicable